Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

Frédéric Pouliot; Fred Saad; Etienne Rousseau; Patrick O. Richard; Atefeh Zamanian; Stephan Probst; Éric Lévesque; Vincent Castonguay; Nicolas Marcoux; Michele Lodde; Daniel Juneau; Zineb Hamilou; Jean-Baptiste Lattouf; François-Alexandre Buteau; Michel Pavic; Jean-François Castilloux; Bertrand Neveu; Guillaume F. Bouvet; Catherine Allard; Amélie Tétu; Brigitte Guérin; Jean-Mathieu Beauregard; for the 3TMPO Investigators

doi:10.2967/jnumed.124.268020

Research ArticleFEATURED ARTICLE OF THE MONTH

Open Access

Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O. Richard, Atefeh Zamanian, Stephan Probst, Éric Lévesque, Vincent Castonguay, Nicolas Marcoux, Michele Lodde, Daniel Juneau, Zineb Hamilou, Jean-Baptiste Lattouf, François-Alexandre Buteau, Michel Pavic, Jean-François Castilloux, Bertrand Neveu, Guillaume F. Bouvet, Catherine Allard, Amélie Tétu, Brigitte Guérin, Jean-Mathieu Beauregard and for the 3TMPO Investigators

Journal of Nuclear Medicine November 2024, 65 (11) 1710-1717; DOI: https://doi.org/10.2967/jnumed.124.268020

Frédéric Pouliot

1Oncology Axis, CHU de Québec–Université Laval Research Center, Quebec City, Quebec, Canada;

2Division of Urology, Department of Surgery, Université Laval, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Fred Saad

3Division of Urology, Department of Surgery, Centre Hospitalier de l’Université de Montréal, Université de Montréal, Montréal, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Etienne Rousseau

4Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, Sherbrooke, Quebec, Canada;

5Sherbrooke Molecular Imaging Centre, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Patrick O. Richard

6Division of Urology, Department of Surgery, Centre Hospitalier Universitaire de Sherbrooke and Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Atefeh Zamanian

1Oncology Axis, CHU de Québec–Université Laval Research Center, Quebec City, Quebec, Canada;

7Department of Radiology and Nuclear Medicine, and Cancer Research Centre, Université Laval, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephan Probst

8Division of Nuclear Medicine, Faculty of Medicine, Sir Mortimer B. Davis–Jewish General Hospital, McGill University, Montréal, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Éric Lévesque

9Division of Hemato-Oncology, Department of Medicine, CHU de Québec–Université Laval, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vincent Castonguay

9Division of Hemato-Oncology, Department of Medicine, CHU de Québec–Université Laval, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicolas Marcoux

9Division of Hemato-Oncology, Department of Medicine, CHU de Québec–Université Laval, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michele Lodde

10Surgery Urology Department, CHU de Québec–Université Laval, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Juneau

11Nuclear Medicine, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zineb Hamilou

12Hemato-Oncology, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean-Baptiste Lattouf

3Division of Urology, Department of Surgery, Centre Hospitalier de l’Université de Montréal, Université de Montréal, Montréal, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

François-Alexandre Buteau

7Department of Radiology and Nuclear Medicine, and Cancer Research Centre, Université Laval, Quebec City, Quebec, Canada;

13Division of Nuclear Medicine, Department of Medical Imaging, CHU de Québec–Université Laval, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michel Pavic

14Medical Oncology, Centre Intégré Universitaire de Santé et Services Sociaux de l’Estrie–Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean-François Castilloux

14Medical Oncology, Centre Intégré Universitaire de Santé et Services Sociaux de l’Estrie–Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bertrand Neveu

1Oncology Axis, CHU de Québec–Université Laval Research Center, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guillaume F. Bouvet

1Oncology Axis, CHU de Québec–Université Laval Research Center, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Catherine Allard

15Unité de Recherche Clinique et Épidémiologique, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amélie Tétu

15Unité de Recherche Clinique et Épidémiologique, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brigitte Guérin

4Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, Sherbrooke, Quebec, Canada;

5Sherbrooke Molecular Imaging Centre, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean-Mathieu Beauregard

1Oncology Axis, CHU de Québec–Université Laval Research Center, Quebec City, Quebec, Canada;

7Department of Radiology and Nuclear Medicine, and Cancer Research Centre, Université Laval, Quebec City, Quebec, Canada;

13Division of Nuclear Medicine, Department of Medical Imaging, CHU de Québec–Université Laval, Quebec City, Quebec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue 11

November 1, 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

Journal of Nuclear Medicine Nov 2024, 65 (11) 1710-1717; DOI: 10.2967/jnumed.124.268020

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

Journal of Nuclear Medicine Nov 2024, 65 (11) 1710-1717; DOI: 10.2967/jnumed.124.268020

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

metastatic castration-resistant prostate cancer
molecular imaging
PET
intrapatient intermetastatic heterogeneity
IIH

Main menu

User menu

Search

Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords